Some of the conditions related to low thyroid function include weight gain, loss of muscle mass, confused speech, swollen neck, dementia, menstrual abnormalities, constipation, headaches, backaches, brittle hair, poor circulation and poor glucose regulation. Patients may also a thinning of the hair on the outer end of the eye brows (a sure, tell-tale sign of hypothyroidism).
By naturally stimulating the function of the thyroid glands, it may be possible to reduce symptoms of chronic hypothyroidism.
L-tyrosine is a precursor to the thyroid hormones T4 (thyroxine) and T3 (triiodothyronine). It is necessary to synthesize the inactive T4, which can then be converted into the active T3. Taking an L-tyrosine supplement may therefore increase thyroid hormone levels and alleviate some signs of hypothyroidism.
L-tyrosine is a precursor to the thyroid hormone thyroxine (T4). This hormone can also be converted into T3, which is the active form of thyroid hormone.
L-tyrosine also affects the pituitary gland’s signaling for increased production of thyroid stimulating hormone (TSH). This determines how much T3 and T4 the thyroid produces.
If using L-tyrosine for thyroid support, dosages of between 500 mg – 1000 mg, taken 2 or 3 times daily are recommended.
Tyrosine should not be taken with food to improve absorption from the intestinal track
L-tyrosine has received Generally Recognized as Safe (GRAS) status by the FDA in the United States. No serious side effects have been observed at dosage levels typically present in foods or at higher dosages of up to 12,000 mg per day.
In some cases, mild side effects of nausea, diarrhea, vomiting or headache have been reported at high doses.
source – http://nootriment.com/l-tyrosine-for-thyroid/
- Jongkees BJ1, Hommel B1, Kühn S2, Colzato LS3. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands-A review. J Psychiatr Res. 2015 Nov;70:50-7. doi: 10.1016/j.jpsychires.2015.08.014. Epub 2015 Aug 25.
- Ahmed RM1, Latheef S2, Bartley L2, Irish M2, Halliday GM2, Kiernan MC2, Hodges JR2, Piguet O1. Eating behavior in frontotemporal dementia: Peripheral hormones vs hypothalamic pathology. Neurology. 2015 Oct 13;85(15):1310-7. doi: 10.1212/WNL.0000000000002018. Epub 2015 Sep 16.
- Qiu HM1, Yang JX, Jiang XH, Hu XY, Liu D, Zhou QX. Enhancing tyrosine hydroxylase and tryptophan hydroxylase expression and improving oxidative stress involved in the antidepressant effect of sodium valproate on rats undergoing chronic unpredicted stress. Neuroreport. 2015 Oct 28. [Epub ahead of print]
- Sarantis K1, Tsiamaki E1, Kouvaros S1, Papatheodoropoulos C1, Angelatou F1. Adenosine A2A receptors permit mGluR5-evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: a possible key mechanism in NMDA receptor modulation. J Neurochem. 2015 Aug 25. doi: 10.1111/jnc.13291. [Epub ahead of print]
- Simone J1, Bogue EA2, Bhatti DL3, Day LE4, Farr NA5, Grossman AM6, Holmes PV7. Ethinyl estradiol and levonorgestrel alter cognition and anxiety in rats concurrent with a decrease in tyrosine hydroxylase expression in the locus coeruleus and brain-derived neurotrophic factor expression in the hippocampus. Psychoneuroendocrinology. 2015 Aug 28;62:265-278. doi: 10.1016/j.psyneuen.2015.08.015. [Epub ahead of print]
- Huang Q1, Zhou C1, Chen X2, Dong B1, Chen S1, Zhang N3, Liu Y4, Li A5, Yao M2, Miao J2, Li Q1, Wang Z1. Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib. PLoS One. 2015 Oct 29;10(10):e0141395. doi: 10.1371/journal.pone.0141395.